Hr-positive Breast Cancer
📧 Sign up to get email alerts when something new happens for Hr-positive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-09-15FDA Approved: KISQALI — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Kisqali (ribociclib) from Novartis Pharmaceuticals Corporation, expanding its labeling for u…